We are live on ! Find out more
EAM

Erste Asset Management Portfolio holdings

AUM $12.9B
1-Year Est. Return 52.69%
This Fund
S&P 500
This Quarter Est. Return
+1.67%
1 Year Est. Return
+52.69%
3 Year Est. Return
+142.55%
5 Year Est. Return
+182.36%
10 Year Est. Return
–
AUM
$4.46B
AUM Growth
-$31.4M
Cap. Flow
-$425K
Cap. Flow %
-0.01%
Top 10 Hldgs %
18.46%
Holding
585
New
11
Increased
191
Reduced
114
Closed
25

Top Buys

Rank Stock Value
1
NUE icon
Nucor
NUE
+$25M
2
FLNC icon
Fluence Energy
FLNC
+$11.7M
3
STEM icon
Stem
STEM
+$9.05M
4
SNOW icon
Snowflake
SNOW
+$6.96M
5
MRK icon
Merck
MRK
+$6.42M

Top Sells

Rank Stock Value
1
TGT icon
Target
TGT
+$22.5M
2
ENPH icon
Enphase Energy
ENPH
+$20.7M
3
BEP icon
Brookfield Renewable
BEP
+$16.4M
4
NVDA icon
NVIDIA
NVDA
+$13.4M
5
AAPL icon
Apple
AAPL
+$10.8M

Sector Composition

Rank Sector Weight
1 Technology 29.44%
2 Healthcare 20.57%
3 Consumer Discretionary 11.4%
4 Financials 9.12%
5 Industrials 8.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FICO icon
476
Fair Isaac
FICO
$22.5B
$260K 0.01%
600
– –
ADPT icon
477
Adaptive Biotechnologies
ADPT
$3.97B
$245K 0.01%
35,700
– –
VOYA icon
478
Voya Financial
VOYA
$9.19B
$244K 0.01%
4,000
– –
KYMR icon
479
Kymera Therapeutics
KYMR
$8.94B
$243K 0.01%
11,000
– –
MORF
480
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$238K 0.01%
8,500
– –
RCKT icon
481
Rocket Pharmaceuticals
RCKT
$394M
$234K 0.01%
16,700
– –
PKG icon
482
Packaging Corp of America
PKG
$22.8B
$228K 0.01%
2,000
-2,000
-50% -$271K
FNF icon
483
Fidelity National Financial
FNF
$13.5B
$228K 0.01%
6,552
– –
CMRX
484
DELISTED
Chimerix, Inc.
CMRX
$224K 0.01%
121,000
– –
SANA icon
485
Sana Biotechnology
SANA
$980M
$223K 0.01%
40,000
– –
IMGN
486
DELISTED
Immunogen Inc
IMGN
$221K ﹤0.01%
47,000
– –
OWL icon
487
Blue Owl Capital
OWL
$18.5B
$217K ﹤0.01%
23,460
– –
ZNTL icon
488
Zentalis Pharmaceuticals
ZNTL
$300M
$211K ﹤0.01%
9,800
– –
FMTX
489
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$207K ﹤0.01%
10,400
– –
KROS icon
490
Keros Therapeutics
KROS
$221M
$207K ﹤0.01%
5,700
– –
ARQT icon
491
Arcutis Biotherapeutics
ARQT
$3.18B
$207K ﹤0.01%
11,100
– –
REPL icon
492
Replimune Group
REPL
$1.01B
$198K ﹤0.01%
11,900
– –
ERAS icon
493
Erasca
ERAS
$6.39B
$198K ﹤0.01%
25,000
– –
SGMO
494
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$185K ﹤0.01%
38,000
– –
BILI icon
495
Bilibili
BILI
$7.84B
$183K ﹤0.01%
12,000
– –
EDIT icon
496
Editas Medicine
EDIT
$442M
$182K ﹤0.01%
15,000
– –
RNAM
497
DELISTED
Avidity Biosciences
RNAM
$182K ﹤0.01%
10,900
– –
ALEC icon
498
Alector
ALEC
$198M
$180K ﹤0.01%
19,000
– –
AVXL icon
499
Anavex Life Sciences
AVXL
$310M
$176K ﹤0.01%
18,000
– –
TDOC icon
500
Teladoc Health
TDOC
$1.3B
$174K ﹤0.01%
6,649
– –
18 19
20
21 22

Similar funds

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
AAMU
APG Asset Management US New York $13B AUM 5.3% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $12.7B AUM 17.31% 1-Year Est. Return
ACA
Aptus Capital Advisors Fairhope, Alabama $12.7B AUM 17.41% 1-Year Est. Return

Erste Asset Management's Q3 2022 Portfolio in Review

As of Q3 2022, Erste Asset Management held 585 positions worth $4.46B, down 0.7% from $4.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Erste Asset Management's Q3 2022 filing shows 11 new, 191 increased, 114 reduced and 25 closed positions. Its largest new stake was Fluence Energy: 775,000 shares worth $11.1M. The largest sale was Target, an estimated $22.5M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Erste Asset Management's largest Q3 2022 buy was Fluence Energy: 775,000 shares worth $11.1M.
  • Erste Asset Management added most to Nucor in Q3 2022, an estimated $25M increase.
  • Erste Asset Management's biggest Q3 2022 reduction was Target, cutting an estimated $22.5M.
  • Erste Asset Management fully exited Brookfield Renewable in Q3 2022, selling an estimated $16.4M.
  • Erste Asset Management's ten largest holdings make up 18% of its $4.46B portfolio in Q3 2022.
  • Erste Asset Management opened 11 new positions and closed 25 in Q3 2022.
  • Erste Asset Management's portfolio value fell 0.7% quarter-over-quarter to $4.46B.

Based on Erste Asset Management's 13F filing for Q3 2022, filed 26 Nov 2024.